There were 1,861 press releases posted in the last 24 hours and 403,624 in the last 365 days.

New CDC Vital Signs: Lethal, Drug-resistant Bacteria Spreading in U.S. Healthcare Facilities - March 5, 2013 - Digital Press Kit

  • CRE germs kill up to half of patients who get bloodstream infections from them

    CRE germs kill up to half of patients who get bloodstream infections from them

    This is a description for image 1

  • Vutal Signsweb graphic

    4% & 18% - About 4% of the 4,000 US hospitals studied had at least one patient with a serious CRE infection during the first half of 2012. About 18% of the country’s 200 long-term acute care hospitals had one. This totals nearly 200 facilities with at least one CRE patient in six months.

    42 - One type of CRE infection has been reported in medical facilities in 42 states during the last 10 years.

    1 in 2 CRE germs kill up to half of patients who get bloodstream infections from them.

    This is a description for image 1

  • Vutal Signs web graphic

    Vital Signs Graphics 2

    This is a description for image 1

  • Klebsiella pneumoniae

    Klebsiella pneumoniae

    This is a description for image 1

  • Lab worker Kitty Anderson

    CDC’s Kitty Anderson holds up a 96-well plate used for testing the ability of bacteria to growth in the presence of antibiotics.

    This is a description for image 1

  • CDC staff show two plates growing bacteria

    CDC staff show two plates growing bacteria in the presence of discs containing various antibiotics. The isolate on the left plate is susceptible to the antibiotics on the discs and is therefore unable to grow around the discs. The one on the right has a CRE that is resistant to all of the antibiotics tested and is able to grow near the disks.

    This is a description for image 1

  • CDC’s Tatiana Travis sets up real-time polymerase chain reaction

    CDC’s Tatiana Travis sets up real-time polymerase chain reaction (PCR) test to detect drug-resistant pathogens, including CRE.

    This is a description for image 1

  • CDC’s Tatiana Travis sets up real-time polymerase chain reaction

    CDC microbiologist, Tatiana Travis, sets up real-time polymerase chain reaction (PCR) test to detect drug-resistant pathogens, including CRE.

    This is a description for image 1

  • CDC microbiologist, Kitty Anderson

    CDC microbiologist, Kitty Anderson, looks at a 96-well plate used for testing the ability of bacteria to growth in the presence of antibiotics.

    This is a description for image 1

  • CDC microbiologist, Johannetsy Avillan

    CDC microbiologist, Johannetsy Avillan, holds up a plate that demonstrates the modified Hodge test, which is used to identify resistance in bacteria known as Enterobacteriaceae. Bacteria that are resistant to carbapenems, considered “last resort” antibiotics, produce a distinctive clover-leaf shape.

    This is a description for image 1

  • CDC microbiologist, Kitty Anderson

    CDC microbiologist, Kitty Anderson, looks at a 96-well plate used for testing the ability of bacteria to grow in the presence of antibiotics.

    This is a description for image 1

  • CDC microbiologist, Kitty Anderson

    CDC microbiologist, Johannetsy Avillan, holds up a plate that demonstrates the modified Hodge test, which is used to identify resistance in bacteria known as Enterobacteriaceae. Bacteria that are resistant to carbapenems, considered “last resort” antibiotics, produce a distinctive clover-leaf shape.

    This is a description for image 1

  • CDC microbiologist, Alicia Shams

    CDC microbiologist, Alicia Shams, demonstrates Klebsiella pneumoniae growing on a MacConkey agar plate. Klebsiella pneumoniae is the most common Enterobacteriaceae that is drug resistant.

    This is a description for image 1